Main container

A phase II, randomized, open-label study to assess the efficacy, safety, and pharmacokinetics (PK) of maintenance cabozantinib (XL184) plus best supportive care (BSC) versus BSC in children, adolescents and young adults (AYA) with unresectable residual...

Titolo
A phase II, randomized, open-label study to assess the efficacy, safety, and pharmacokinetics (PK) of maintenance cabozantinib (XL184) plus best supportive care (BSC) versus BSC in children, adolescents and young adults (AYA) with unresectable residual...
Codice
CabOSTar
Tipo
Sperimentale con farmaco
Anno avvio
2024
Stato
In Corso

Sperimentatore principale

Unità operative che promuovono lo studio

Documenti e video allegati

Ti potrebbe interessare anche

Studi clinici
Terapia orientata alla matrice in adolescenti vicini all’età adulta e adulti affetti da osteogenesi imperfetta – studio “MOI-A”
Leggi tutto
Studi clinici
A Multi-Centre Clinical Investigation To Evaluate The Safety And Performance Of The Freedom Total Knee® System With The PEEK-OPTIMA™ Femoral Component
Leggi tutto
Studi clinici
Pediatric Oncological Orthopaedic Reconstructions: analysis of the clinical and radiographic results
Leggi tutto
Contenuto aggiornato il
25/06/2024 17:01